Antineutrophil Cytoplasmic Antibody–Associated Rapid Progressive Glomerulonephritis after Pembrolizumab Treatment in Thymic Epithelial Tumor: A Case Report-Reference-Cited by-同舟云学术

Antineutrophil Cytoplasmic Antibody–Associated Rapid Progressive Glomerulonephritis after Pembrolizumab Treatment in Thymic Epithelial Tumor: A Case Report

Published:2017-08 Issue:8 Volume:12 Page:e103-e105
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Heo Mi Hwa,Kim Hee Kyung,Lee Hansang,Ahn Myung-Ju

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference5 articles.

1. Murakami N, Motwani S, Riella LV. Renal complications of immune checkpoint blockade [e-pub ahead of print]. Curr Probl Cancer. http://dx.doi.org/10.1016/j.currproblcancer.2016.12.004, accessed April 6, 2017.

2. Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors;Cortazar;Kidney Int,2016

3. Thymoma and autoimmunity;Shelly;Cell Mol Immunol,2011

4. A phase II study of pembrolizumab in patients with recurrent thymic carcinoma;Giaccone;J Clin Oncol,2016

5. OA18. 03 Safety and clinical activity of avelumab (MSB0010718C; anti-PD-L1) in patients with advanced thymic epithelial tumors (TETs);Rajan;J Thorac Oncol,2017

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing Cancer Treatment in Patients with Renal Dysfunction: The Role of Chemotherapy;Anti-Cancer Agents in Medicinal Chemistry;2023-10

2. MPO-ANCA positive glomerulonephritis during PD-1 inhibitor combined with anti-CTLA4 antibody in lung cancer;Journal of Chemotherapy;2023-05-14

3. Targeting immune checkpoints in anti-neutrophil cytoplasmic antibodies associated vasculitis: the potential therapeutic targets in the future;Frontiers in Immunology;2023-04-06

4. Rapidly Progressive Pauci-Immune Glomerulonephritis with Aberrant Fibrinoid Necrosis Associated with Atezolizumab, an Immune Check Point Inhibitor: A Case Report and Review of Literature;Antibodies;2023-01-25

5. Autoimmunity and Cancer;Handbook of Cancer and Immunology;2023